The seeds of Parkinson's disease: amyloid... - Cure Parkinson's

Cure Parkinson's

25,909 members27,218 posts

The seeds of Parkinson's disease: amyloid fibrils that move through the brain

Farooqji profile image
4 Replies

Using X-ray imaging of post mortem brains, researchers from Osaka University find α-synuclein aggregates that can move through the brain before developing into Lewy bodies, the hallmark of Parkinson's disease

eurekalert.org/pub_releases...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
4 Replies
sunvox profile image
sunvox

Iq-

Again you are excellent at finding interesting articles, but I think it imperative that you add some discussion so folks can understand what is or is not of value. My interpretation of this study is first that Parkinson's Disease is NOT "prion like" meaning you can't "catch" the disease from someone else, and second I disagree completely that aggregation is part of the toxicity of alpha-synuclein. People can do their own research, but here is but one of many papers that came to this conclusion and here is a quote from the paper:

-

α-Synuclein misfolding and Parkinson's disease

sciencedirect.com/science/a...

"This data allows us to make a conclusion that, similar to other neurodegenerative diseases, there is a lack of correlation between α-synuclein fibril accumulation and neurotoxicity, making it likely that oligomers are the neurotoxic species."

-

It is my opinion and the reason for all my post on HU related to Parkinson's that alpha-synuclein becomes toxic in patients with Parkinson's because it forms an oligomer, and THAT is the single common denominator in the majority of Parkinson's cases. The problem lies in the variation in the cause of the mutation AND the type of mutation.

-

Here are several studies and articles that underly my belief:

ncbi.nlm.nih.gov/pubmed/295...

scienceofparkinsons.com/201...

ncbi.nlm.nih.gov/pubmed/294...

ncbi.nlm.nih.gov/pmc/articl...

and a Phase 2 clinical trial of a drug for the treatment of Parkinson's based on the theory of alpha-sy as a toxic oligomer:

prothena.com/pipeline/prx002/

-

Cheers,

Joe in NY

ddmagee1 profile image
ddmagee1 in reply to sunvox

Thank you, Joe, for sharing this important information! Your thorough research into characteristics of alpha-synuclein, is intriguing.

Rosenmu profile image
Rosenmu in reply to sunvox

Still trying to get through all of your links but I keep getting sidetracked by other information and chasing rabbit holes, one of which is Ecoli and it's effect on alpha synuclein, oxidative stress, peptides as immunotherapy, lymphocyte-activation gene 3, known as LAG3, misfolded PrP90-231 and on and on. Not sure if this has been read or discussed, lots of interesting things being discovered.

ncbi.nlm.nih.gov/pmc/articl...

scienceofparkinsons.com/201...

MarionP profile image
MarionP

Definitely something to this...and I think that Joe is correct.

You may also like...

Is Parkinson's Disease brain fog a precursor to dementia?

found between PD brain fog and dementia appearing in the same set of people in research studies?...

Caffeine shown to affect brain dopamine function in patients with Parkinson's disease

patients with Parkinson's disease, shows a new international study led by the University of Turku...

Parkinson's Disease: emerging treatment target, the NLRP inflammasome.

cycle of neuroinflammation and α-synuclein buildup in the brain....

New and current hope for Parkinson's Disease

Sorry, we didn't find She at first was told she had PD and we went through all the usual emotional...

Vascular Dysfunction in the Brain as an Initiating Event in Parkinson’s Disease

https://parkinsonsnewstoday.com/forums/forums/reply/20641/ The concept that Parkinson’s disease is...